Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and November 2017

Showing 1 to 10 of 362
Title Reference number Published Last updated
Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxane Reference number:TA458 TA00458 Published:July 2017 20170701 Last updated:November 2017 20171120
Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours Reference number:TA488 TA00488 Published:November 2017 20171101 Last updated:November 2017 20171115
Venetoclax for treating chronic lymphocytic leukaemia Reference number:TA487 TA00487 Published:November 2017 20171101 Last updated:November 2017 20171108
Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma Reference number:TA462 TA00462 Published:July 2017 20170701 Last updated:November 2017 20171107
Nivolumab for previously treated advanced renal cell carcinoma Reference number:TA417 TA00417 Published:November 2016 20161101 Last updated:November 2017 20171107
Nivolumab for previously treated squamous non-small-cell lung cancer Reference number:TA483 TA00483 Published:November 2017 20171101 Last updated:November 2017 20171101
Nivolumab for previously treated non-squamous non-small-cell lung cancer Reference number:TA484 TA00484 Published:November 2017 20171101 Last updated:November 2017 20171101
Sarilumab for moderate to severe rheumatoid arthritis Reference number:TA485 TA00485 Published:November 2017 20171101 Last updated:November 2017 20171101
Aflibercept for treating choroidal neovascularisation Reference number:TA486 TA00486 Published:November 2017 20171101 Last updated:November 2017 20171101
Tofacitinib for moderate to severe rheumatoid arthritis Reference number:TA480 TA00480 Published:October 2017 20171001 Last updated:October 2017 20171011